News
Date:
The Agilent 708-DS Dissolution Apparatus and Agilent 850-DS Dissolution Sampling Station are two of the most popular solutions available for your dissolution testing requirements.
With so many of these instruments in use across the world, we often get questions regarding parts, setup, and general…
Date:
This article summarizes selected patents in the area of controlled release or delivery that were issued from August 31, 2021 through December 7, 2021. Greater detail on each of these patents is given on the U.S. patent website https://patft.uspto.gov.…
Date:
Members of the Women in Science executive board met in December to plan 2022 activities. From top to bottom, left to right: Maria Jose Alonso, Andrea Joseph, Sujuan Ba, Ruth Schmid, Sara Cordeiro, Renata F. V. Lopez, Nidhi Raval, Danchen Gao, and Ana Cadete.…
Date:
PRNewswire: March 14, 2017 – SAN DIEGO, CA, U.S.A. – OncoSec Medical Incorporated (“OncoSec”) (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that they have entered into a technology access program (TAP) agreement with Inhibrx, LP, a privately…
Date:
Business Wire: October 24, 2016 – STOCKHOLM, Sweden – Braeburn Pharmaceuticals and Camurus (STO: CAMX) today announced the expansion of their collaboration and license agreement from 2014 to include buprenorphine combination products. The first drug candidate within the expanded scope (CAM2058) is…
Date:
PRNewswire: September 1, 2016 – MISSISSAUGA, Ontario, Canada – Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the company), a drug development company that owns topical products for use in the treatment of medical conditions related to dermatology and pain, today announced that it has acquired…
